2021 NOSCM | Myelodysplasia: Biomarkers, Risk Assessment and Novel Treatments

2021 NOSCM | Myelodysplasia: Biomarkers, Risk Assessment and Novel Treatments

Overview

NA

Target Audience

NA

This material is non‑CME, no credits are available, and a certificate will not be provided upon completion.

Faculty

Rami Komrokji, MD

Date of Release

May 14th, 2025